Tiziana Life Sciences Ltd

US$0.69As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:TLSAHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (15.02%)
Div yield —
ROE (780.60%)
Biotechnology
Beta (5Y) 0.46
PE TTM —
TSR TTM (64.12%)
Mkt cap US$88.19M
ROIC (389.08%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.654
(4.99%)
(71.40%)
Hold 5|3|10|4|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
25.24%
22.49%
30.65%
26.16%
Revenue$M
5.190
5.062
5.272
5.399
1.19%
(1.50%)
2.39%
5.75%
Peers (US$88.19M)
Cap (US$)
PE
110.0M
—
62.15M
—
87.97M
—
Capital
TTM
5Y
10Y
Leveragex
1.991
0.100
0.097
EBIT/Intx
0.995
1.103
1.185
Own earn%
54.03
(134.11)
(123.70)
Sh yield%
7.80
37.49
37.52
Owners
Insiders/Inst%
7.02
21.36
Short interest%
3.73
SBC / revenue%
5.25
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
5–10
$1 testx
—
Incr. ROIC%
2